A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder

NCT00249236 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

291

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Disorder
Manic Episode

Interventions

DRUG: Risperidone, oral tablets

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.